Viewing Study NCT00968435

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-03-29 @ 8:38 PM
Study NCT ID: NCT00968435
Status: COMPLETED
Last Update Posted: 2016-08-10
First Post: 2009-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bevacizumab View
None cisplatin View
None cetuximab View
None radiation therapy View
None Phase II View
None 09-083 View